Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices

[1]  R. Cheng,et al.  The shock team: a multidisciplinary approach to early patient phenotyping and appropriate care escalation in cardiogenic shock , 2022, Current opinion in cardiology.

[2]  M. Link,et al.  2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2022, Journal of the American College of Cardiology.

[3]  M. Fong,et al.  Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockers , 2022, International journal of cardiology. Heart & vasculature.

[4]  B. Harbaoui,et al.  Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry , 2021, ESC heart failure.

[5]  N. Kapur,et al.  Left ventricular unloading before percutaneous coronary intervention is associated with improved survival in patients with acute myocardial infarction complicated by cardiogenic shock: A systematic review and meta-analysis. , 2021, Cardiovascular revascularization medicine : including molecular interventions.

[6]  Andrew J. Sauer,et al.  Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database , 2021, Journal of the American Heart Association.

[7]  S. Fernando,et al.  Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. , 2021, The New England journal of medicine.

[8]  B. Kheiri,et al.  Fifteen‐Year Trends in Incidence of Cardiogenic Shock Hospitalization and In‐Hospital Mortality in the United States , 2021, Journal of the American Heart Association.

[9]  A. Lala,et al.  Patient Referral Practices to Advanced Heart Failure Centers. , 2021, Journal of cardiac failure.

[10]  L. Stoletniy,et al.  A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure , 2021, Journal of cardiovascular pharmacology.

[11]  D. Morrow,et al.  Epidemiology and causes of cardiogenic shock , 2021, Current opinion in critical care.

[12]  J. Bakker,et al.  Current use of inotropes in circulatory shock , 2021, Annals of Intensive Care.

[13]  D. Baran,et al.  Prospective validation of the SCAI shock classification: Single center analysis , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  E. Brilakis,et al.  Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies. , 2020, International journal of cardiology.

[15]  D. Burkhoff,et al.  Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock , 2020, Circulation. Heart failure.

[16]  L. Otterspoor,et al.  Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis , 2020, Journal of clinical medicine.

[17]  G. Filippatos,et al.  Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.

[18]  A. Wong,et al.  Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review , 2020, Annals of translational medicine.

[19]  J. Kobashigawa,et al.  A new paradigm in mechanical circulatory support: 100 patient experience. , 2020, The Annals of thoracic surgery.

[20]  S. Hollenberg,et al.  Vasopressor and Inotrope Therapy in Cardiac Critical Care , 2020, Journal of intensive care medicine.

[21]  D. Burkhoff,et al.  Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. , 2020, Circulation.

[22]  T. Henry,et al.  Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit. , 2019, Journal of the American College of Cardiology.

[23]  E. Ohman,et al.  Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.

[24]  J. Ornato,et al.  SCAI clinical expert consensus statement on the classification of cardiogenic shock , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[25]  L. Stevenson,et al.  Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock. , 2019, Journal of cardiac failure.

[26]  D. Morrow,et al.  EPIDEMIOLOGY OF SHOCK IN CONTEMPORARY CARDIAC INTENSIVE CARE UNITS: DATA FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY , 2019, Journal of the American College of Cardiology.

[27]  D. Morrow,et al.  Epidemiology of Shock in Contemporary Cardiac Intensive Care Units: Data From the Critical Care Cardiology Trials Network Registry , 2019, Circulation. Cardiovascular quality and outcomes.

[28]  A. Mebazaa,et al.  Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[29]  S. van Diepen.  Norepinephrine as a First-Line Inopressor in Cardiogenic Shock: Oversimplification or Best Practice? , 2018, Journal of the American College of Cardiology.

[30]  O. Bodger,et al.  Mechanical assist devices for acute cardiogenic shock. , 2018, The Cochrane database of systematic reviews.

[31]  H. Thiele,et al.  Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. , 2018, The Cochrane database of systematic reviews.

[32]  H. Thiele,et al.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.

[33]  E. Ohman,et al.  Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association , 2017, Circulation.

[34]  N. Kapur,et al.  Acute mechanical circulatory support for cardiogenic shock: the “door to support” time , 2017, F1000Research.

[35]  A. Mebazaa,et al.  Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study , 2019, Journal of intensive care medicine.

[36]  Sunil V. Rao,et al.  Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock , 2017, Circulation. Cardiovascular interventions.

[37]  D. Burkhoff,et al.  Hemodynamics of Mechanical Circulatory Support. , 2015, Journal of the American College of Cardiology.

[38]  H. Bøtker,et al.  Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study , 2015, Critical Care.

[39]  J. Haerting,et al.  Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. , 2015, The Cochrane database of systematic reviews.

[40]  K. Werdan,et al.  Kardiogener Schock , 2014, Deutsche Medizinische Wochenschrift.

[41]  J. Hochman,et al.  Mechanical circulatory support in cardiogenic shock. , 2014, European heart journal.

[42]  W. O’Neill,et al.  The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry , 2013, Journal of interventional cardiology.

[43]  A. Mebazaa,et al.  The Effectiveness of Inodilators in Reducing Short Term Mortality among Patient with Severe Cardiogenic Shock: A Propensity-Based Analysis , 2013, PloS one.

[44]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[45]  Sarabjeet Singh,et al.  Cardiovascular Outcomes Using Intra-Aortic Balloon Pump in High-Risk Acute Myocardial Infarction With or Without Cardiogenic Shock , 2012, Journal of cardiovascular pharmacology and therapeutics.

[46]  M. Drazner,et al.  Successful use of the TandemHeart percutaneous ventricular assist device as a bridge to recovery for acute cellular rejection in a cardiac transplant patient. , 2011, Transplantation proceedings.

[47]  P. Loyalka,et al.  The percutaneous ventricular assist device in severe refractory cardiogenic shock. , 2011, Journal of the American College of Cardiology.

[48]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[49]  J. Tijssen,et al.  A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? , 2008, European heart journal.

[50]  D. Burkhoff,et al.  A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.

[51]  Monica R. Shah,et al.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .

[52]  G. Schuler,et al.  Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.

[53]  G. Schuler,et al.  Reversal of Cardiogenic Shock by Percutaneous Left Atrial-to-Femoral Arterial Bypass Assistance , 2001, Circulation.

[54]  D. Burkhoff,et al.  Pathophysiology and Advanced Hemodynamic Assessment of Cardiogenic Shock. , 2020, Methodist DeBakey cardiovascular journal.

[55]  W. Cohn,et al.  Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation. , 2008, Texas Heart Institute journal.

[56]  W. Cohn,et al.  The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). , 2008, Texas Heart Institute journal.

[57]  H. S,et al.  Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2000 .